1
Home
Companies

JCR Pharmaceuticals

JCR Pharmaceuticals
Leadership team

Mr. Shin Ashida (Chairman, CEO & Pres)

Yoshihiro Ota (Director of Accounting Department & Corp. Strategy Department (Fin.))

Yutaka Honda (Sr. Corp. Officer,Exec. Director of Admin. Divs. & Director of Gen. Affairs Dept)

Products/ Services
Biopharma, Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Hyogo, Hokkaido, Japan
Established
1975
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
TYO:4552
Social Media
URL
https://www.jcrpharm.co.jp
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
History

JCR Pharmaceuticals was established in 1890 as a chemical and drug producer. The company grew significantly in the 1950s and expanded into drug discovery, production, and distribution. JCR is a leader in both pharmaceuticals and biotechnology and is one of the few Japanese companies to be a global leader in both fields.

Mission
JCR Pharmaceuticals Co., Ltd.’s mission is to provide innovative and reliable medications to improve the health and quality of life of patients around the world.
Vision
JCR Pharmaceuticals Co., Ltd.’s vision is to be a leader in the research, development, and production of innovative medications to treat a wide range of diseases and improve the health and wellness of people worldwide.
Key Team

Hiroyuki Fukuya (Director of Legal Affairs Department - Admin. Division)

Toru Ashida (Sr. VP of Sales & Admin., Exec. Director of Sales Division and Director)

Ryutaro Makino (Director of Marketing Dept. & Group Mang. of Product Planning - Marketing Dept. for Sales Div.)

Yoshiaki Ijiri (Director of HR Planning Dept.)

Katsuya Nishino (Exec. VP)

Tatsuo Suzuki Ph.D. (MD, GM of Quality Assurance Division & Director of Regulatory Affairs)

Hiroshi Yoshimoto (Sr. Advisor)

Recognition and Awards
JCR Pharmaceuticals has been recognized for its innovative and reliable medicines with numerous awards, including the Japan Pharmaceutical Manufacturers Association Grand Prize in 2002 for its anti-cancer medicine, Xeloda.
References

https://in.investing.com/equities/jcr-pharmaceuticals

https://finance.yahoo.com/quote/4552.T/profile?p=4552.T

https://www.crunchbase.com/organization/jcr-pharmaceuticals

https://companiesmarketcap.com/

https://www.jcrpharm.co.jp

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

JCR Pharmaceuticals
Leadership team

Mr. Shin Ashida (Chairman, CEO & Pres)

Yoshihiro Ota (Director of Accounting Department & Corp. Strategy Department (Fin.))

Yutaka Honda (Sr. Corp. Officer,Exec. Director of Admin. Divs. & Director of Gen. Affairs Dept)

Products/ Services
Biopharma, Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Hyogo, Hokkaido, Japan
Established
1975
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
TYO:4552
Social Media
URL
https://www.jcrpharm.co.jp